Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives a presentation on the combining novel agents for treating myelofibrosis (MF) at the 14th International Congress on Myeloproliferative Neoplasms (MPNs) held in New York City, NY.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.